I Liked MMG & Enact on Ofex, however not a fan of Ximed or Biogeny.

However there is another one.

105 year old company that probably a few haven't noticed has changed direction, Relugas as was, changed in 2000 & then no one has been interested as the bear market has taken hold.


However, the best time to take stakes is to invest when no one wants to invest, because you will get value ....since then since march last year the market has picked up strongly.

Look at MMG up 8 fold, Protherics (ex Enact) rise every month, Ximed has zoomed to 21m mkt cap.


This company is valued at a tiny 0.72m, but has 4 investments so far,(with 2 more to come i believe) net cash, & assets include investments at cost.

I quote

quote:
--------------------------------------------------------------------------------
It seems that diagnostics has now
become rather more attractive to early stage investors so there is some
investor competition for new businesses holding strong patents on particularly
attractive prospects.


--------------------------------------------------------------------------------



Furthermore it may raise a significant sum of cash...I quote:

quote:
--------------------------------------------------------------------------------
However, as I stated at the time of the interim figures, your directors are
very aware that our company needs to raise a substantial fund to take advantage
of some of the more interesting biotechnology/life sciences prospects.
Unfortunately the market for raising funds has been particularly difficult
during the past eighteen months but there are now signs of a more positive
sentiment especially following the substantial amount of money raised by
Schroder Ventures for this sector a few weeks ago. We have already prepared an
Information Memorandum as a draft for a significant fund raising as soon as
conditions are appropriate.

--------------------------------------------------------------------------------



So it may become much more highlighted on investors radar screens on the above completion.



Furthermore it has some exciting investments which must have patents & IP & has turned down over 250 from various prominent Universities throughout the country.


One for instance which has a much shorter lead time for start up & revenue generation is Bio Analysis

A spin out from Oxford University it offers a Bio Analytical service to pharmaceuticals for the measurement of monoclonal antibodies in clinical trial studies....mono antibodies are a rapidly growing sector and the drugs whose development is extremely demanding offer some of the most effective new treatments for a wider range of disease.

Cherwell owns 9.2% of this Co & as I say it's at cost in the balance sheet.


It also has a 3% stake in a company that develops a miniaturised satellite location & tracking device with built in telemetry. Applications can monitor valuable goods, children, people with Altzimers etc.

Another stake is in a company which helps the brain learn languages easier.

For more information download the Annual report from the Ofex site.

Also commitments for another 2 investments.




It occurs to me, while all other stocks have had a re-rating in this sector Cherwell may have been ignored,

1) It was a different Co for 102 years.
2) It changed direction just three years ago when big bear started
3) Who knows of it as a pure Bio play (see Ofex for accurate description)


So for me you can keep your 21m mkt cap Ximed...not saying it won't do well, but the excitement of a 720,000 mkt cap, with blue sky potential is more my cup of tea.


To my mind the stakes although I can't say with expert opinion, are probably way more valuable than the balance sheet suggests, but of course, they may be worth very little, it appears they have close links with the University of Oxford & indeed have a small Office in the City, so they may have a close relationship, this in itself is adds value in my opinion.


Also Note running cost are very reasonable, a company with a long history & then chnage of direction is just the sort of situation that sometimes (but only sometimes) develops into a very decent winner.

Spot on Xmortal, lets turn the tables on him and start debating his tips, by the way all dead losses. Cheers GF. ps, cant help thinking though that we wont see him for a while, mind hes out on advfn this evening so hes not away.

You guys obviously know little about small companies they don't move like liquid ones can go up 100,200% in a day, as for this one I'm in profit & holding.

Please please tell us one single, reason and fundamental for you even suggest this is gonna be a sucess? As as I can see there is more sound fundamental to invest in RAB than this one u suggest. YOU are ramping this by saying this can get u money. and like it can go up 100.200% in can go down as weel that %. If any moderators are reading this please, this guy must be removed. He is very likely to cause people to loose money.

All,

Rest assured we monitor these threads. Can everyone please stick to the share and not their opinions of individual posters here.

Ian

Thank-you Money AM.

With a mkt cap of 500k, directors who never took a single penny in remuneration last year & investments in blue sky situations, the excitement is obvious as they can multiply by many 100's of % in value.

It has limited downside due to mkt cap & even has net cash.


If anyone wants to make a negative case against it, please do....I don't whinge if other views are put forward. Please give it some fundamental research though :-)

No trades for three months. That's dead money. Likely to return to basis price soon, I think, knowing how ofex work, if that situation continues, which would make trading even harder.

Regardless of fundamentals that's enough negatives for me. Not a squeak from the company about when any of their investments will ever float. Could be very many years.

Dead money for far too long imho.

Better to put the money in the bank and look again if we ever hear anything worthwhile. At present rate could be 105 more years, taken rather a long time to get this far! And a few who bought in February are likely imho to get fed up and sell, making the shares cheaper. These tiny incubators are at the very highest end of risk. There are millions of new ideas out there, over 99% of which will most likely never see the light of day. No reason to think Cherwell any different.

Yup, very dead money.

But has the price gone down like more liquid stocks such as RAB on AIM which is one you hold, to make my point, many of AIM's stocks have had a correction while little unknowns & unresearched stocks have been solid on Ofex.

When it does go up, it could easily double on a positive announcement about one of it's investments, and even then the mkt cap would only be circa 1m.


A money raising exercise & therefore more liquidity may also have a positive effect, a check on newsflow will see that this is a likely possibilty.

Sorry Hawick i have to disagree with you on one of your points, the stock hasnt moved since thirdeye ramped it up on this board in January, yes thats right six months on no evidence of a share being bought or sold, please check the chart out.

But yet we were told it has some exciting investments, you will get value, the market as picked up strongly, and attractive prospects there are more just check out his header, then we were told by thirdeye on the chart post above that the share had " volume every day , what a change in sentiment".

Two words spring to mind 'Charlie Carolie'.

cheers GF.

So no negative fundamental analysis then?

Big fuss about a share that has moved up since highlighted. The volume spike on the the year chart will show the interest at the time, plus it hasn't fell back despite being illiquid, like many stocks on AIM just recently, which suggests investors buy these tiny micro's long term & are patient to see results.

:-)

It moved for 6 days in all and then finito, and I would suggest all on the back of thirdeyes ramp and most probably bought by his chums, all 6 of them.

How one can justify that hyped up heading tosh is beyond me and then still defend it.

It just goes to show the author cannot say "no I got it wrong, I appologise" .

Nothing wrong with admiting to ones mistakes, we all at some stage pick dogs.

cheers GF.

Newsflow drives shares goldfinger.

Nothing wrong at all, I'm in profit I could sell, but I have no wish to.

Looking forward to next newsflow thank-you.


Now do you want to denbate the fundamentals or have you not researched the investments they have?

"im in profit I could sell" me me me me me.

Just about sums you up thirdeye, no thoughts for the investors who you could have put into this and are now sitting on a loss. (look at the date he tipped it here)

Perhaps now and again on your tips including this one you could update having said that there aint any newsflow anyway.

Yawn , snore, Im waiting for the next century to see some action, wake me up then.

cheers GF.

So you have no idea of the investments they have?

As I thought, just another personal attack.

All,

There is, as with every argument 2 sides, please can both sides refrain from commenting on other posters. Please stick to the subject at hand.

Ian

Thank you Money AM


Anyone wish to discuss Cherwell?

Yes thankyou Ian, and I think that if investors are going to recommend shares on this board they should give a little more thought for there fellow posters, a little more responsibilty wouldnt go amiss and thats for all.

cheers GF.

Yes I can see now that newsflow as really pushed volumes and the share price along.

Blue sky potential?????????????????????????????????????????????.

cheers GF.

As stated on the 5th September 2003 by the CEO..........................

However, as I stated at the time of the interim figures, your directors are
very aware that our company needs to raise a substantial fund to take advantage
of some of the more interesting biotechnology/life sciences prospects.
Unfortunately the market for raising funds has been particularly difficult
during the past eighteen months but there are now signs of a more positive
sentiment especially following the substantial amount of money raised by
Schroder Ventures for this sector a few weeks ago. We have already prepared an
Information Memorandum as a draft for a significant fund raising as soon as
conditions are appropriate.ENDS.

Well still no sign of that fund raising and if anything the market for raising funds as taken a steep drop this last month, just look at the new issues that are floating now and the number of firms that are having to go from a placing to a subscription, and lets not forget what the boss said "your directors are
very aware that our company needs to raise a substantial fund to take advantage
of some of the more interesting biotechnology/life sciences prospects" doesnt look very healthy to me. And if you check the balance sheet out well!.

cheers GF.

Exactly what I have said.

Funds will put this unknown stock on many radars.


Net cash is healthy. For instance g/f you invest in companies with well over 100% gearing, how can you say net cash in unhealthy?

Very unhealthy, this one. No trades since February, no price change since january. Dead money. Needs a fundraising and can't possibly hope to attract serious investment with that sort of record.

Management not paying themselves, suspect no funds available to do so.

And no sign of any of its companies floating in foreseeable future. A miniscule incubator with little hope of attracting new funds therefore. Would think their holdings are virtually untradeable too, so that throttles the already chronic illiquidity even further.

Over 99% of new ideas end in the bin. This one could be heading there too.

Sell imho if you are unlucky enough to have any.

Going nowhere.

Dead money.